Otsuka 

€15.9
0
-€0.6-3.64% Friday 17:47

Statistics

Day High
15.9
Day Low
15.8
52W High
19.6
52W Low
15.5
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5MayExpected
Q4 2025
Next
0.22
0.23
0.24
0.25
Expected EPS
0.21661570258260002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OTK.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap321.08B
Roche operates in similar pharmaceutical and diagnostics segments, competing directly in the development of innovative drugs and health solutions.
Pfizer
PFE
Mkt Cap161.09B
Pfizer competes in the pharmaceutical sector, offering a wide range of products that overlap with Otsuka's portfolio, including mental health medications.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson's broad healthcare portfolio, including pharmaceuticals and medical devices, positions it as a competitor across several of Otsuka's business areas.
Novartis
NVS
Mkt Cap297.32B
Novartis competes in pharmaceuticals and healthcare, offering products in areas like neurology and psychiatry, directly competing with Otsuka's offerings.
Merck
MRK
Mkt Cap298.84B
Merck operates in the pharmaceutical industry, competing with Otsuka in areas such as healthcare solutions and drug development.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, with its strong presence in the pharmaceuticals sector, competes in areas of mutual interest like neuroscience and oncology.
Takeda Pharmaceutical
TAK
Mkt Cap59.2B
Takeda Pharmaceutical Company has a significant overlap with Otsuka in the pharmaceutical sector, especially in Japan, competing in similar therapeutic areas.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline competes with Otsuka in the pharmaceutical and healthcare sectors, including areas like mental health.
Sanofi
SNY
Mkt Cap116.63B
Sanofi operates globally in the pharmaceutical sector, competing with Otsuka in various therapeutic areas, including mental health and neurology.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global competitor in the pharmaceutical industry, with a product range that competes with Otsuka's, especially in the oncology and neurology segments.

About

Otsuka Corporation provides system integration, support, and other services in Japan. The System Integration Business segment offers system services, including consulting, system design and development, transport and installation work, and network construction. It also provides management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks. In addition, this segment sells computers, copiers, and communications equipment and software; and develops consigned software. The Service and Support Business segment offers supplies, hardware and software maintenance, telephone support, and outsourcing services; emergency computer rescue services for corporate and individual clients; and network support and services for the planning, design, construction, and operation of corporate information systems, as well as out-sources system engineers. It also provides educational support services. The company was founded in 1961 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Yuji Otsuka
Employees
9680
Country
United States
ISIN
JP3188200004

Listings

0 Comments

Share your thoughts

FAQ

What is Otsuka stock price today?
The current price of OTK.STU is €15.9 EUR — it has decreased by -3.64% in the past 24 hours. Watch Otsuka stock price performance more closely on the chart.
What is Otsuka stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Otsuka stocks are traded under the ticker OTK.STU.
Is Otsuka stock price growing?
OTK.STU stock has fallen by -4.79% compared to the previous week, the month change is a +0% rise, over the last year Otsuka has showed a -13.11% decrease.
When is the next Otsuka earnings date?
Otsuka is going to release the next earnings report on May 05, 2026.
What were Otsuka earnings last quarter?
OTK.STU earnings for the last quarter are 0.25 EUR per share, whereas the estimation was 0.24 EUR resulting in a +4.19% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Otsuka have?
As of April 13, 2026, the company has 9,680 employees.
In which sector is Otsuka located?
Otsuka operates in the Technology sector.
When did Otsuka complete a stock split?
Otsuka has not had any recent stock splits.
Where is Otsuka headquartered?
Otsuka is headquartered in Tokyo, United States.